Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Lack of sterility assurance.
cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Failed Impurities/Degradation Specifications
Marketed without an approved NDA/ANDA: FDA analysis has found the product to be tainted with sildenafil
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.